These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 10203611)

  • 1. Technetium-99m methylene diphosphonate scintimammography for evaluation of palpable breast masses.
    Lee JK; Kao CH; Sun SS
    Oncol Rep; 1999; 6(3):659-63. PubMed ID: 10203611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Technetium-99m-methylene diphosphonate scintimammography to image primary breast cancer.
    Piccolo S; Lastoria S; Mainolfi C; Muto P; Bazzicalupo L; Salvatore M
    J Nucl Med; 1995 May; 36(5):718-24. PubMed ID: 7738640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of Tc-99m methoxyisobutylisonitrile scintimammography as compared to mammography in evaluating palpable breast masses of Taiwanese women.
    Sun SS; Hsieh JF; Tsai SC; Ho YJ; Lee JK; Kao CH
    Anticancer Res; 2000; 20(3B):2133-6. PubMed ID: 10928166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tc-99m tetrofosmin scintigraphy as an adjunct to plain-film mammography in palpable breast lesions.
    Fenlon HM; Phelan N; Tierney S; Gorey T; Ennis JT
    Clin Radiol; 1998 Jan; 53(1):17-24. PubMed ID: 9464430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The comparison of dual phase Tc-99m MIBI and tc-99m MDP scintimammography in the evaluation of breast masses: preliminary report.
    Arslan N; Ozturk E; Ilgan S; Narin Y; Dundar S; Tufan T; Pekcan M; Bayhan H
    Ann Nucl Med; 2000 Feb; 14(1):39-46. PubMed ID: 10770579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delayed Tc-99m citrate scintigraphy in the evaluation of palpable breast masses.
    Mondal A; Sharma R; Chakravarty KL; Mishra P; Sahay K; Bhatnagar A; Gupta A; Sawroop K
    Clin Nucl Med; 1999 May; 24(5):309-13. PubMed ID: 10232466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 99Tcm-MIBI scintimammography in the evaluation of breast lesions and axillary involvement: a comparison with mammography and histopathological diagnosis.
    Arslan N; Oztürk E; Ilgan S; Urhan M; Karaçalioglu O; Pekcan M; Tufan T; Bayhan H
    Nucl Med Commun; 1999 Apr; 20(4):317-25. PubMed ID: 10319351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benign versus malignant breast disease: comparison of contrast-enhanced MR imaging and Tc-99m tetrofosmin scintimammography.
    Fenlon HM; Phelan NC; O'Sullivan P; Tierney S; Gorey T; Ennis JT
    Radiology; 1997 Oct; 205(1):214-20. PubMed ID: 9314988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tc-99m MDP scintimammography in palpable and nonpalpable breast lesions: comparison with mammographic probability of malignancy.
    Atasever T; Ozdemir A; Turkölmez S; Altinok M; Isik S
    Anticancer Res; 1999; 19(4C):3601-6. PubMed ID: 10629658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 99mTc sestamibi scintimammography. Screening mammographic non-palpable suspicious breast lesions: preliminary results.
    Bekiş R; Derebek E; Balci P; Koçdor MA; Değirmenci B; Canda T; Durak H
    Nuklearmedizin; 2004 Feb; 43(1):16-20. PubMed ID: 14978536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scintimammography with 99mTc-MDP in the detection of primary breast cancer.
    Piccolo S; Lastoria S; Muto P; Bazzicalupo L; Bartiromo A; Salvatore M
    Q J Nucl Med; 1997 Sep; 41(3):225-30. PubMed ID: 9274130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tc-99m-tetrofosmin scintimammography: a prospective study in primary breast lesions.
    Lind P; Gallowitsch HJ; Kogler D; Kresnik E; Mikosch P; Gomez I
    Nuklearmedizin; 1996 Dec; 35(6):225-9. PubMed ID: 8976502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scintimammography with Tc-99m MIBI in patients with suspicion of primary breast cancer.
    Palmedo H; Schomburg A; Grünwald F; Mallmann P; Boldt I; Biersack HJ
    Nucl Med Biol; 1996 Aug; 23(6):681-4. PubMed ID: 8940710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. (99M)Technetium-sestamibi scintimammography in non-palpable breast lesions found on screening X-ray mammography.
    Gommans GM; van der Zant FM; van Dongen A; Boer RO; Teule GJ; de Waard JW
    Eur J Surg Oncol; 2007 Feb; 33(1):23-7. PubMed ID: 17126524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Technetium-99m-MIBI scintimammography in palpable and nonpalpable breast lesions.
    Mekhmandarov S; Sandbank J; Cohen M; Lelcuk S; Lubin E
    J Nucl Med; 1998 Jan; 39(1):86-91. PubMed ID: 9443742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Tc-99m THY and Tc-99m MIBI scans for diagnosis of breast lesions.
    Gutfilen B; Fonseca LM
    J Exp Clin Cancer Res; 2001 Sep; 20(3):385-91. PubMed ID: 11718219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Technetium-99m tetrofosmin scintigraphy to evaluate breast lesions.
    Madariaga P; Almoguera I; Alonso A; Escat JL; Vegazo O; Martinez ML; Trampal C; Perez Vazquez JM
    Anticancer Res; 1997; 17(3B):1619-21. PubMed ID: 9179205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic value of 99mTc-methylene diphosphonate and 99mTc-pentavalent DMSA compared with 99mTc-sestamibi for palpable breast lesions.
    Massardo T; Alonso O; Kabasakal L; Llamas-Olier A; Shankar UR; Zhu H; Delgado L; González P; Mut F; Padhy AK
    J Nucl Med; 2002 Jul; 43(7):882-8. PubMed ID: 12097457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scintimammography with technetium-99m tetrofosmin in suspected breast cancer.
    Schillaci O; Scopinaro F; Danieli R; Picardi V; Tavolaro R; Cannas P; Colella AC
    Anticancer Res; 1997; 17(3B):1623-6. PubMed ID: 9179206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of 99m-Tc MIBI and 99m-Tc(V) DMSA scintigraphy in evaluation of breast mass lesions.
    Ambrus E; Rajtár M; Ormándi K; Séra T; Tószegi A; Láng J; Pávics L; Csernay L
    Anticancer Res; 1997; 17(3B):1599-605. PubMed ID: 9179201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.